|
|
||||||||

T Cells Indirectly Regulate Murine Graft-Versus-Host Reactivity Following Donor Leukocyte Infusion Therapy in Mice1



Departments of
*
Medicine and
Biostatistics and
Bone Marrow Transplant Program, Medical College of Wisconsin, Milwaukee, WI 53226
The purpose of this study was to determine whether 
T cells
were able to regulate graft-vs-host (GVH) reactivity mediated by
ß
T cells in murine recipients transplanted with MHC-mismatched marrow
grafts. Studies were conducted using ex vivo-activated 
T cells
because this was a more clinically relevant strategy, and these cells
have been shown to be capable of facilitating alloengraftment without
causing GVH disease (GVHD). Coadministration of activated 
T
cells and naive
ß T cells at the time of bone marrow
transplantation (BMT) significantly exacerbated GVHD when compared with
naive
ß T cells alone. In contrast, when the administration of
naive
ß T cells was delayed for 2 wk post-BMT, survival was
significantly enhanced in mice transplanted with BM plus activated

T cells vs those given marrow cells alone. Mitigation of GVHD by
activated 
T cells occurred only at high doses (150 x
106) and was a unique property of 
T cells, as
activated
ß T cells were incapable of ameliorating the subsequent
development of GVHD. Protection from GVHD was not due to the direct
inhibition of naive
ß T cells by 
T cells. Rather, 
T
cells mediated this effect indirectly through donor BM-derived
ß T
cells that acted as the proximate regulatory population responsible for
the decrease in GVH reactivity. Collectively, these data demonstrate
that activated 
T cells are capable of modulating the ability of
MHC-incompatible nontolerant
ß T cells to cause GVHD after
allogeneic BMT.
This article has been cited by other articles:
![]() |
C. Pabst, H. Schirutschke, G. Ehninger, M. Bornhauser, and U. Platzbecker The Graft Content of Donor T Cells Expressing {gamma}{delta}TCR+ and CD4+foxp3+ Predicts the Risk of Acute Graft versus Host Disease after Transplantation of Allogeneic Peripheral Blood Stem Cells from Unrelated Donors Clin. Cancer Res., May 15, 2007; 13(10): 2916 - 2922. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Zhang, W. Yang, N. Degauque, Y. Tian, A. Mikita, and X. X. Zheng New differentiation pathway for double-negative regulatory T cells that regulates the magnitude of immune responses Blood, May 1, 2007; 109(9): 4071 - 4079. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Maeda, P. Reddy, K. P. Lowler, C. Liu, D. K. Bishop, and J. L. M. Ferrara Critical role of host {gamma}{delta} T cells in experimental acute graft-versus-host disease Blood, July 15, 2005; 106(2): 749 - 755. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Teshima, C. Liu, K. P. Lowler, G. Dranoff, and J. L. M. Ferrara Donor Leukocyte Infusion from Immunized Donors Increases Tumor Vaccine Efficacy after Allogeneic Bone Marrow Transplantation Cancer Res., February 1, 2002; 62(3): 796 - 800. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |